3,000
Participants
Start Date
January 1, 2018
Primary Completion Date
March 31, 2022
Study Completion Date
November 1, 2024
Oslo University Hospital, Oslo
Norwegian Cancer Society
OTHER
South-Eastern Norway Regional Health Authority
OTHER
Oslo University Hospital
OTHER